What is the most recent earnings date for CMPX stock?
COMPASS THERAPEUTICS INC (CMPX) last reported earnings on 3/5/2026.
NASDAQ:CMPX • US20454B1044
Past quarterly earnings results for COMPASS THERAPEUTICS INC (CMPX), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).
EPS & Revenue History (in USD): Actual vs estimated values, surprises, q2q growth and acceleration numbers quarterly history.
| Quarter | EPS | EPS Est | EPS Surprise | EPS Q2Q | Revenue | Revenue Est | Revenue Surprise | Revenue Q2Q |
|---|---|---|---|---|---|---|---|---|
| Q4 2025 | -0.09 | -0.09 | 2.39% | 18.18% | - | - | ||
| Q3 2025 | -0.08 | -0.14 | 42.98% | - | - | - | ||
| Q2 2025 | -0.14 | -0.12 | -12.30% | -40.00% | - | -100.00% | ||
| Q1 2025 | -0.12 | -0.11 | -5.99% | -50.00% | - | - | ||
| Q4 2024 | -0.11 | -0.10 | -9.93% | - | - | - | ||
| Q3 2024 | -0.08 | -0.12 | 30.79% | - | - | - | ||
| Q2 2024 | -0.10 | -0.10 | -3.20% | -11.11% | 850K | - | - | |
| Q1 2024 | -0.08 | -0.12 | 30.51% | -33.33% | - | - | ||
| Q4 2023 | -0.11 | -0.10 | -14.56% | -10.00% | - | - | ||
| Q3 2023 | -0.08 | -0.11 | 26.80% | 33.33% | - | - | ||
| Q2 2023 | -0.09 | -0.08 | -8.36% | -12.50% | - | - | ||
| Q1 2023 | -0.06 | -0.11 | 45.82% | 14.29% | - | - | ||
| Q4 2022 | -0.10 | -0.11 | 12.85% | 52.38% | - | - | ||
| Q3 2022 | -0.12 | -0.11 | -10.29% | -20.00% | - | - | ||
| Q2 2022 | -0.08 | -0.09 | 6.95% | - | - | - | ||
| Q1 2022 | -0.07 | -0.11 | 37.61% | - | - | - | ||
| Q4 2021 | -0.21 | -0.07 | -182.57% | - | - | - | ||
| Q3 2021 | -0.10 | -0.13 | 21.57% | - | - | - | ||
| Q2 2021 | - | - | - | - | ||||
| Q1 2021 | - | - | - | - | ||||
| Q4 2020 | - | - | - | - | ||||
| Q3 2020 | - | - | - | - | ||||
| Q2 2020 | - | - | - | - | ||||
| Q1 2020 | - | - | - | - |
Notes
COMPASS THERAPEUTICS INC (CMPX) last reported earnings on 3/5/2026.
COMPASS THERAPEUTICS INC (CMPX) beat EPS estimates and missed revenue estimates in the most recent quarter.
In the last 4 quarters, COMPASS THERAPEUTICS INC (CMPX) has beaten EPS estimates in 2 out of 4 releases.